跳至主要内容
临床试验/IRCT20181207041876N1
IRCT20181207041876N1尚未招募3 期

The effect of Caraway powder consumption on glycemic indices, lipid profile and Serum levels of nesfatin-1 in overweight and obese patients with type 2 diabetes

Zahedan University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • given diabetes and having a fasting blood suger level of 126 to 250 mg / dL
  • Consumption of oral glucose-lowering medicines
  • Age range of 30 to 65 years
  • Body mass index 25 to 40

排除标准

  • given Chronic diseases (high blood pressure, heart, kidney, hypothyroidism, liver, systemic infection)
  • Pregnancy and lactation
  • Hypersensitivity to Caraway

研究者

发起方
Zahedan University of Medical Sciences

相似试验